Clinically Inflammatory Vitiligo and Rare Variants
暂无分享,去创建一个
[1] M. Cario-André,et al. Follicular vitiligo: A report of 8 cases. , 2016, Journal of the American Academy of Dermatology.
[2] R. Joshi,et al. Amyloidosis Cutis Dyschromica: A Rare Reticulate Pigmentary Dermatosis , 2015, Indian journal of dermatology.
[3] O. Chosidow,et al. Hypochromic vitiligo: delineation of a new entity , 2015, The British journal of dermatology.
[4] N. Comfere,et al. Hypopigmented mycosis fungoides: a clinical mimicker of vitiligo. , 2015, Journal of drugs in dermatology : JDD.
[5] M. Gouveia,et al. Childhood hypopigmented mycosis fungoides: a commonly delayed diagnosis , 2014, BMJ Case Reports.
[6] G. Murphy,et al. Repigmentation of Extensive Inflammatory Vitiligo with Raised Borders Using Early and Aggressive Treatment , 2014, Dermatology.
[7] M. Picardo,et al. Inflammasome activation and vitiligo/nonsegmental vitiligo progression , 2014, The British journal of dermatology.
[8] R. Brodell,et al. Marginal vitiligo: an unusual depigmenting disorder. , 2014, Dermatology online journal.
[9] V. Attili,et al. Segmental and Generalized Vitiligo: Both Forms Demonstrate Inflammatory Histopathological Features and Clinical Mosaicism , 2013, Indian journal of dermatology.
[10] S. Purcell,et al. Inflammatory vitiligo versus hypopigmented mycosis fungoides in a 58-year-old Indian female , 2013, Indian dermatology online journal.
[11] Do Young Kim,et al. New suggestive clue to the mechanism of vitiligo: Inflammatory vitiligo showing prominent leukocytoclasis at the erythematous rim , 2013, The Journal of dermatology.
[12] M. Nishimura,et al. Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo , 2013, Science Translational Medicine.
[13] R. Spritz,et al. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome , 2013, Proceedings of the National Academy of Sciences.
[14] F. Boralevi,et al. Follicular vitiligo: a new form of vitiligo , 2012, Pigment cell & melanoma research.
[15] A. Taïeb. Vitiligo as an inflammatory skin disorder: a therapeutic perspective , 2012, Pigment cell & melanoma research.
[16] M. D. de Silva,et al. Hypopigmented Mycosis Fungoides in Type V Skin: A Report of 5 Cases , 2011, Case reports in dermatological medicine.
[17] M. Tanioka,et al. Narrowband ultraviolet B phototherapy for inflammatory vitiligo with raised borders associated with Sjögren’s syndrome , 2009, Clinical and experimental dermatology.
[18] L. Le,et al. A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis , 2008, International journal of dermatology.
[19] H. Walling,et al. Depigmented patches with an annular inflammatory border , 2008, Clinical and experimental dermatology.
[20] V. Attili,et al. Lichenoid inflammation in vitiligo – a clinical and histopathologic review of 210 cases* , 2008, International journal of dermatology.
[21] A. Traoré,et al. Vitiligo sur peau noire associé au VIH et repigmentation lors du traitement antirétroviral , 2007 .
[22] M. Picardo,et al. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.
[23] K. Katsuoka,et al. Vitiligo with inflammatory raised borders with hepatitis C virus infection , 2006, The Journal of dermatology.
[24] S. Dogra,et al. Spontaneous repigmentation of vitiligo in an untreated HIV‐positive patient , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.
[25] Y. Tokura,et al. Vitiligo with inflammatory raised borders, associated with atopic dermatitis , 2006, Clinical and experimental dermatology.
[26] C. Loquai,et al. Confetti‐like lesions with hyperkeratosis: a novel ultraviolet‐induced hypomelanotic disorder? , 2005, The British journal of dermatology.
[27] K. Sharquie,et al. Inflammatory Changes in Vitiligo: Stage I and II Depigmentation , 2004, The American Journal of dermatopathology.
[28] G. Annessi,et al. Annular lichenoid dermatitis of youth. , 2003, Journal of the American Academy of Dermatology.
[29] M. Bagot,et al. Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides. , 2003, European journal of dermatology : EJD.
[30] M. Ishii,et al. Inflammatory vitiligo in Vogt-Koyanagi-Harada disease. , 2001, Journal of the American Academy of Dermatology.
[31] Y. Tokura,et al. Vitiligo with raised inflammatory borders: involvement ofT cell immunity and keratinocytes expressing MHC class IIand ICAM-1 molecules , 2000 .
[32] S. Ng,et al. Vogt-Koyanagi-Harada Disease: Extensive Vitiligo with Prodromal Generalized Erythroderma , 1999, Dermatology.
[33] S. Im,et al. Epidermal Changes in Active Vitiligo , 1992, The Journal of dermatology.
[34] R. Falabella,et al. Leukoderma punctata. , 1988, Journal of the American Academy of Dermatology.
[35] M. Duvic,et al. Human immunodeficiency virus—associated vitiligo: Expression of autoimmunity with immunodeficiency? , 1987, Journal of the American Academy of Dermatology.
[36] J. Ortonne,et al. [Vitiligo with an inflammatory border. Apropos of 2 cases with review of the literature (18 cases)]. , 1979, Annales de dermatologie et de venereologie.
[37] G. Michaëlsson. Vitiligo with raised borders. Report of two cases. , 1968, Acta dermato-venereologica.
[38] W. Lobitz,et al. [Vitiligo with a raised inflammatory border]. , 1953, A.M.A. archives of dermatology and syphilology.
[39] F. Wise,et al. Vitiligo with raised borders. , 1948, Archives of dermatology and syphilology.
[40] F. Wise,et al. XANTHOMA DIABETICORUM WITH UNUSUAL FORM OF ERUPTION , 1942 .